Juan
Ayllon Barasoain
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications en collaboration avec des chercheurs de GlaxoSmithKline (United Kingdom) (2)
2020
-
Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay
Vaccine, Vol. 38, Núm. 8, pp. 1953-1961
2018
-
Influenza virus infection causes global RNAPII termination defects
Nature Structural and Molecular Biology, Vol. 25, Núm. 9, pp. 885-893